NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $346,000 | -3.6% | 9,733 | -8.9% | 0.02% | -5.6% |
| Q1 2019 | $359,000 | -0.3% | 10,682 | -2.4% | 0.02% | -18.2% |
| Q4 2018 | $360,000 | -48.0% | 10,950 | -3.6% | 0.02% | -33.3% |
| Q3 2018 | $692,000 | +33.1% | 11,356 | +6.7% | 0.03% | +32.0% |
| Q2 2018 | $520,000 | -46.4% | 10,646 | +16.6% | 0.02% | -44.4% |
| Q1 2018 | $970,000 | +78.6% | 9,133 | +0.5% | 0.04% | +150.0% |
| Q4 2017 | $543,000 | +119.8% | 9,088 | -11.6% | 0.02% | +125.0% |
| Q3 2017 | $247,000 | +24.1% | 10,281 | +1.1% | 0.01% | +14.3% |
| Q2 2017 | $199,000 | -11.9% | 10,167 | +5.6% | 0.01% | 0.0% |
| Q1 2017 | $226,000 | +79.4% | 9,628 | -11.9% | 0.01% | +133.3% |
| Q2 2013 | $126,000 | – | 10,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |